BGM (BGM Group) Research & Development: $0.67 Mil (TTM As of Sep. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BGM BGM Group Ltd BGM
35 GF Score
Price $0.29
GF Value $0.26
Valuation Fairly Valued
! 7 Warning Signs
View Full Analysis

What is BGM Group Research & Development?

BGM Group BGM 35 Research & Development is $0.67 Mil as of Sep. 2025. GuruFocus rates BGM with a GF Score™ of 35/100 and a GF Value™ of $0.26 (Fairly Valued). The stock has 7 warning signs investors should review.

Research & Development is the aggregate amount of research and development expenses during the year. BGM Group's Research & Development for the six months ended in Sep. 2025 was $0.15 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Sep. 2025 was $0.67 Mil.

BGM Group  (NAS:BGM) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

BGM Group Research & Development Related Terms

BGM Group Research & Development Historical Data

* Premium members only.

The historical data trend for BGM Group's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

BGM Group Research & Development Chart

BGM Group Annual Data
Trend Sep17 Sep18 Sep19 Sep20 Sep21 Sep22 Sep23 Sep24 Sep25
Research & Development
Get a 7-Day Free Trial Premium Member Only 0.00 1.22 0.57 1.36 0.67

BGM Group Semi-Annual Data
Sep17 Mar18 Sep18 Mar19 Sep19 Mar20 Sep20 Mar21 Sep21 Mar22 Sep22 Mar23 Sep23 Mar24 Sep24 Mar25 Sep25
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.30 0.47 0.89 0.53 0.15
BGM
35GF Score
BGM Group Ltd BGM
Research & Development is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

BGM Group Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Sep. 2025 adds up the semi-annually data reported by the company within the most recent 12 months, which was $0.67 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Research & Development →
What does a Research & Development of $0.67 Mil mean?
BGM Group (BGM) has a Research & Development of $0.67 Mil as of Sep. 2025. Research and development expense is the total cost for research and development activities. View historical data on BGM Group and its competitors.
Is BGM Group's Research & Development too high?
BGM Group's current Research & Development is $0.67 Mil. Overall, BGM Group has a GF Score™ of 35/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does BGM Group's Research & Development compare to CPIX and ADCT?
BGM Group's Research & Development of $0.67 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Research & Development for a Drug Manufacturers company?
A good Research & Development depends on the Drug Manufacturers industry context. However, Research & Development should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Research & Development mean?
A high Research & Development can signal that a stock is expensive relative to its fundamentals. Research and development expense is the total cost for research and development activities. View historical data on BGM Group and its competitors. BGM Group's current Research & Development is $0.67 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is BGM Group stock overvalued right now?
Based on GuruFocus' analysis, BGM Group (BGM) is currently considered Fairly Valued. The stock's GF Value™ is $0.26, compared to a current price of $0.29 — trading 9.7% above its estimated fair value. The current Research & Development is $0.67 Mil. BGM Group's overall GF Score™ is 35/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Research & Development calculated?
Research & Development is calculated from a company's financial statements. For BGM Group (BGM), the current Research & Development is $0.67 Mil as of Sep. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is BGM Group (BGM) Overvalued in 2026?

Based on GuruFocus' analysis, BGM Group stock appears to be overvalued. The current stock price of $0.29 is trading 9.7% above its estimated GF Value™ of $0.26. GuruFocus considers BGM Group to be Fairly Valued.

Key valuation signals for BGM:

  • Research & Development: $0.67 Mil
  • GF Value™: $0.26 vs. price of $0.29 (9.7% above fair value)
  • GF Score™: 35/100 with 7 warning signs

No single metric tells the full story. See the BGM stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

BGM Group Business Description

Address No. 152 Hongliang East 1st Street No. 1703, Tianfu New District, Chengdu, CHN, 610200
BGM Group Ltd is a biopharmaceuticals, bio-extraction, and medical health business. Its product range includes oxytetracycline APIs, licorice preparations, and crude heparin sodium. Maximum revenue is from Oxytetracycline & Licorice and TCMD, followed by Heparin products and Sausage casing.
35GF Score

Get the complete analysis for BGM

Research & Development is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.29
Price
$0.26
GF Value